The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products ...

The FDA on Thursday authorized the marketing of 20 ZYN nicotine pouches, including flavors ... The firm, which has a Sell rating and $105 price target on the shares, says U.S. ZYN is 7% of ...

The FDA said its move Thursday was based on studies showing that the Zyn pouches contain "substantially ... dividend yield of 4.53% at current stock prices. The yield on the consumer staples ...

Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...

Lingering inflation and market uncertainty are sending investors in search of defensive assets. Click here for top 5 ...

In this photo illustration, ZYN nicotine cases and pouches are seen on a table on ... maker Vectura Group Ltd. for roughly a third of the price it paid just three years ago. The $1.2 billion ...

To Olczak’s frustration, Zyn and other nicotine pouches have not yet been authorized ... Vectura Group Ltd. for roughly a third of the price it paid just three years ago. The $1.2 billion ...

Investing in profitable companies when their stock prices offer high yields can ... like iQOS heat-not-burn tobacco sticks and Zyn nicotine pouches, which it gained in its 2022 acquisition of ...

If the items were genuine, they would have carried manufacturer's suggested retail prices totaling $29,989 ... okayed the marketing of 20 Zyn nicotine pouch products after undertaking an extensive ...